Metaplasticity of Hypothalamic Synapses following In Vivo Challenge

Neuron

Volumn 62, Issue 6, 2009, Pages 839-849

  Kuzmiski, J Brent ^a,b   Pittman, Quentin J ^a,b   Bains, Jaideep S ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

MOLNEURO; SIGNALING

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ENDOCANNABINOID; GLUTAMIC ACID; METABOTROPIC RECEPTOR; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONTROLLED STUDY; HOMEOSTASIS; HYPOTHALAMUS; HYPOVOLEMIA; LONG TERM DEPRESSION; MALE; NERVE CELL PLASTICITY; NEUROSECRETORY CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR DOWN REGULATION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANIMALS, NEWBORN; BIOPHYSICS; CARBOLINES; CLONIDINE; DOWN-REGULATION; DRUG INTERACTIONS; EGTAZIC ACID; ELECTRIC STIMULATION; EXCITATORY AMINO ACID AGENTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; GUANOSINE DIPHOSPHATE; HYPOTHALAMUS; INTRACRANIAL HEMORRHAGES; LONG-TERM SYNAPTIC DEPRESSION; MALE; MICROINJECTIONS; NEURONS; PATCH-CLAMP TECHNIQUES; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, METABOTROPIC GLUTAMATE; SYNAPSES; THIONUCLEOTIDES; YOHIMBINE;

EID: 67249088502     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2009.05.027     Document Type: Article

References (70)

1. Abraham W.C. Metaplasticity: tuning synapses and networks for plasticity. Nat. Rev. Neurosci. 9 (2008) 387-399
2. Basavarajappa B.S. Critical enzymes involved in endocannabinoid metabolism. Protein Pept. Lett. 14 (2007) 237-246
3. Bi G.Q., and Poo M.M. Synaptic modifications in cultured hippocampal neurons: dependence on spike timing, synaptic strength, and postsynaptic cell type. J. Neurosci. 18 (1998) 10464-10472
4. Blevins J.E., Stanley B.G., and Reidelberger R.D. DMSO as a vehicle for central injections: tests with feeding elicited by norepinephrine injected into the paraventricular nucleus. Pharmacol. Biochem. Behav. 71 (2002) 277-282
5. Boudaba C., Di S., and Tasker J.G. Presynaptic noradrenergic regulation of glutamate inputs to hypothalamic magnocellular neurones. J. Neuroendocrinol. 15 (2003) 803-810
6. Bourque C.W. Central mechanisms of osmosensation and systemic osmoregulation. Nat. Rev. Neurosci. 9 (2008) 519-531
7. Brown S.P., Safo P.K., and Regehr W.G. Endocannabinoids inhibit transmission at granule cell to Purkinje cell synapses by modulating three types of presynaptic calcium channels. J. Neurosci. 24 (2004) 5623-5631
8. Buller K.M., Smith D.W., and Day T.A. Differential recruitment of hypothalamic neuroendocrine and ventrolateral medulla catecholamine cells by non-hypotensive and hypotensive hemorrhages. Brain Res. 834 (1999) 42-54
9. Carey M.R., and Regehr W.G. Noradrenergic Control of Associative Synaptic Plasticity by Selective Modulation of Instructive Signals. Neuron 62 (2009) 112-122
10. Carr D.B., Andrews G.D., Glen W.B., and Lavin A. alpha 2-Noradrenergic receptors activation enhances excitability and synaptic integration in rat prefrontal cortex pyramidal neurons via inhibition of HCN currents. J. Physiol. 584 (2007) 437-450
11. Cathala L., Guyon A., Eugene D., and Paupardin-Tritsch D. alpha(2)-adrenoceptor activation increases a cationic conductance and spontaneous gabaergic synaptic activity in dopaminergic neurones of the rat substantia nigra. Neuroscience 115 (2002) 1059-1065
12. Chevaleyre V., and Castillo P.E. Heterosynaptic LTD of hippocampal GABAergic synapses: A novel role of endocannabinoids in regulating excitability. Neuron 38 (2003) 461-472
13. Chevaleyre V., Takahashi K.A., and Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu. Rev. Neurosci. 29 (2006) 37-76
14. Chevaleyre V., Heifets B.D., Kaeser P.S., Sudhof T.C., Purpura D.P., and Castillo P.E. Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1 alpha. Neuron 54 (2007) 801-812
15. Clem R.L., Celikel T., and Barth A.L. Ongoing in vivo experience triggers synaptic metaplasticity in the neocortex. Science 319 (2008) 101-104
16. Delaney A.J., Crane J.W., and Sah P. Noradrenaline modulates transmission at a central synapse by a presynaptic mechanism. Neuron 56 (2007) 880-892
17. Di S., Boudaba C., Popescu I.R., Weng F.J., Harris C., Marcheselli V.L., Bazan N.G., and Tasker J.G. Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. J. Physiol. 569 (2005) 751-760
18. Di S., Malcher-Lopes R., Marcheselli V.L., Bazan N.G., and Tasker J.G. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology 146 (2005) 4292-4301
19. Di S., Maxson M.M., Franco A., and Tasker J.G. Glucocorticoids regulate glutamate and GABA synapse-specific retrograde transmission via divergent nongenomic signaling pathways. J. Neurosci. 29 (2009) 393-401
20. Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., and Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372 (1994) 686-691
21. Gerdeman G., and Lovinger D.M. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol. 85 (2001) 468-471
22. Gerdeman G.L., Ronesi J., and Lovinger D.M. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5 (2002) 446-451
23. Giuffrida A., Parsons L.H., Kerr T.M., Rodriguez de Fonseca F., Navarro M., and Piomelli D. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 2 (1999) 358-363
24. Gordon G.R.J., and Bains J.S. Priming of excitatory synapses by alpha(1) adrenoceptor-mediated inhibition of group III metabotropic glutamate receptors. J. Neurosci. 23 (2003) 6223-6231
25. Gordon G.R.J., and Bains J.S. Noradrenaline triggers multivesicular release at glutamatergic synapses in the hypothalamus. J. Neurosci. 25 (2005) 11385-11395
26. Gordon G.R.J., Baimoukhametova D.V., Hewitt S.A., Rajapaksha W.R.A.K., Fisher T.E., and Bains J.S. Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy. Nat. Neurosci. 8 (2005) 1078-1086
27. Hirasawa M., Schwab Y., Natah S., Hillard C.J., Mackie K., Sharkey K.A., and Pittman Q.J. Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain. J. Physiol. 559 (2004) 611-624
28. Hoffman A.F., and Lupica C.R. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J. Neurosci. 20 (2000) 2470-2479
29. 2+-independent phosphatidylethanolamine N-acyltransferase generating the anandamide precursor and its congeners. J. Biol. Chem. 282 (2007) 3614-3623
30. Jinsi-Parimoo A., and Deth R.C. Reconstitution of alpha 2D-adrenergic receptor coupling to phospholipase D in a PC12 cell lysate. J. Biol. Chem. 272 (1997) 14556-14561
31. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., and Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 89 (2009) 309-380
32. Kombian S.B., Zidichouski J.A., and Pittman Q.J. GABA(B) receptors presynaptically modulate excitatory synaptic transmission in the rat supraoptic nucleus in vitro. J. Neurophysiol. 76 (1996) 1166-1179
33. Kreitzer A.C., and Regehr W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29 (2001) 717-727
34. Kreitzer A.C., and Malenka R.C. Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J. Neurosci. 25 (2005) 10537-10545
35. Kreitzer A.C., and Malenka R.C. Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature 445 (2007) 643-647
36. Lee H.B., and Blaufox M.D. Blood-Volume in the Rat. J. Nucl. Med. 26 (1985) 72-76
37. Li Y., and van den Pol A.N. Direct and indirect inhibition by catecholamines of hypocretin/orexin neurons. J. Neurosci. 25 (2005) 173-183
38. Liu W., and Alreja M. Norepinephrine inhibits neurons of the intermediate subnucleus of the lateral septum via alpha(2)-adrenoceptors. Brain Res. 806 (1998) 36-54
39. Lovinger D.M. Presynaptic modulation by endocannabinoids. Handb. Exp. Pharmacol. 184 (2008) 435-477
40. Luther J.A., and Tasker J.G. Voltage-gated currents distinguish parvocellular from magnocellular neurones in the rat hypothalamic paraventricular nucleus. J. Physiol. 523 (2000) 193-209
41. Macek T.A., Schaffhauser H., and Conn P.J. Activation of PKC disrupts presynaptic inhibition by group II and group in metabotropic glutamate receptors and uncouples the receptor from GTP-binding proteins. Ann. NY Acad. Sci. 868 (1999) 554-557
42. Malcher-Lopes R., Di S., Marcheselli V.S., Weng F.J., Stuart C.T., Bazan N.G., and Tasker J.G. Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release. J. Neurosci. 26 (2006) 6643-6650
43. Malenka R.C., and Bear M.F. LTP and LTD: An embarrassment of riches. Neuron 44 (2004) 5-21
44. Mathiesen J.M., and Ramirez M.T. The metabotropic glutamate receptor 4 is internalized and desensitized upon protein kinase C activation. Br. J. Pharmacol. 148 (2006) 279-290
45. Melis M., Pistis M., Perra S., Muntoni A.L., Pillolla G., and Gessa G.L. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J. Neurosci. 24 (2004) 53-62
46. Oliet S.H.R., Piet R., and Poulain D.A. Control of glutamate clearance and synaptic efficacy by glial coverage of neurons. Science 292 (2001) 923-926
47. Oliet S.H.R., Baimoukhametova D.V., Piet R., and Bains J.S. Retrograde regulation of GABA transmission by the tonic release of oxytocin and endocannabinoids governs postsynaptic firing. J. Neurosci. 27 (2007) 1325-1333
48. Panatier A., Poulain D.A., and Oliet S.H.R. Regulation of transmitter release by high-affinity group III mGluRs in the supraoptic nucleus of the rat hypothalamus. Neuropharmacology 47 (2004) 333-341
49. Panatier A., Gentles S.J., Bourque C.W., and Oliet S.H.R. Activity-dependent synaptic plasticity in the supraoptic nucleus of the rat hypothalamus. J. Physiol. 573 (2006) 711-721
50. Panatier A., Theodosis D.T., Mothet J.P., Touquet B., Pollegioni L., Poulain D.A., and Oliet S.H.R. Glia-derived D-serine controls NMDA receptor activity and synaptic memory. Cell 125 (2006) 775-784
51. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (2005), Elsevier/Academic Press, Amsterdam
52. Pelkey K.A., Lavezzari G., Racca C., Roche K.W., and McBain C.J. mGluR7 is a metaplastic switch controlling bidirectional plasticity of feedforward inhibition. Neuron 46 (2005) 89-102
53. 2+ channel regulation at divergent mossy-fiber release sites underlies target cell-dependent plasticity. Neuron 52 (2006) 497-510
54. Pelkey K.A., Yuan X.Q., Lavezzari G., Roche K.W., and McBain C.J. mGluR7 undergoes rapid internalization in response to activation by the allosteric agonist AMN082. Neuropharmacology 52 (2007) 108-117
55. Pelkey K.A., Topolnik L., Yuan X.Q., Lacaille J.C., and McBain C.J. State-dependent cAMP sensitivity of presynaptic function underlies metaplasticity in a hippocampal feedforward inhibitory circuit. Neuron 60 (2008) 980-987
56. Poulain D.A., and Wakerley J.B. Electrophysiology of hypothalamic magnocellular neurones secreting oxytocin and vasopressin. Neuroscience 7 (1982) 773-808
57. Poulain D.A., Wakerley J.B., and Dyball R.E.J. Electrophysiological differentiation of oxytocin- and vasopressin-secreting neurones. Proc. R. Soc. Lond. B. Biol. Sci. 196 (1977) 367-384
58. Robbe D., Alonso G., Duchamp F., Bockaert J., and Manzoni O.J. Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens. J. Neurosci. 21 (2001) 109-116
59. Robbe D., Kopf M., Remaury A., Bockaert J., and Manzoni O.J. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc. Natl. Acad. Sci. USA 99 (2002) 8384-8388
60. Ronesi J., and Lovinger D.M. Induction of striatal long-term synaptic depression by moderate frequency activation of cortical afferents in rat. J. Physiol. 562 (2005) 245-256
61. Sawchenko P.E., and Swanson L.W. Central noradrenergic pathways for the integration of hypothalamic neuroendocrine and autonomic responses. Science 214 (1981) 685-687
62. Schrader L.A., and Tasker J.G. Presynaptic modulation by metabotropic glutamate receptors of excitatory and inhibitory synaptic inputs to hypothalamic magnocellular neurons. J. Neurophysiol. 77 (1997) 527-536
63. Senogles S.E. The D2s dopamine receptor stimulates phospholipase D activity: A novel signaling pathway for dopamine. Mol. Pharmacol. 58 (2000) 455-462
64. Shirasaka T., Kannan H., and Takasaki M. Activation of a G protein-coupled inwardly rectifying K+ current and suppression of I-h contribute to dexmedetomidine-induced inhibition of rat hypothalamic paraventricular nucleus neurons. Anesthesiology 107 (2007) 605-615
65. Suh Y.H., Pelkey K.A., Lavezzari G., Roche P.A., Huganir R.L., McBain C.J., and Roche K.W. Corequirement of PICK1 binding and PKC phosphorylation for stable surface expression of the metabotropic glutamate receptor mGluR7. Neuron 58 (2008) 736-748
66. Sung K.W., Choi S., and Lovinger D.M. Activation of group I mGluRs is necessary for induction of long-term depression at Striatal synapses. J. Neurophysiol. 86 (2001) 2405-2412
67. Ueda N., Liu Q., and Yamanaka K. Marked activation of the N-acylphosphatidylethanolamine-hydrolyzing phosphodiesterase by divalent cations. Biochim. Biophys. Acta 1532 (2001) 121-127
68. Wakerly J.B., Poulain D.A., Dyball R.E.J., and Cross B.A. Activity of phasic neurosecretory cells during hemorrhage. Nature 258 (1975) 82-84
69. Yamanaka A., Muraki Y., Ichiki K., Tsujino N., Kilduff T.S., Goto K., and Sakurai T. Orexin neurons are directly and indirectly regulated by catecholamines in a complex manner. J. Neurophysiol. 96 (2006) 284-298
70. Yin H.H., and Lovinger D.M. Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc. Natl. Acad. Sci. USA 103 (2006) 8251-8256